ArticleDrug delivery and translational research2026

Genetically bio-engineered PD-L1 targeted exosomes for immunotherapy of resistant triple negative breast cancer.

Mounika Aare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.